Is TScan Therapeutics, Inc. (TCRX) a Buy, Sell, or Hold?
NASDAQ : TCRX
TScan Therapeutics, Inc. — Competitors
$0.773 USD
$0.0 (-0.49%)
- Volume
- 523.99K
- Average Volume
- 829.65K
- Market Capitalization
- $47.21M
- P/E Ratio
- -0.85
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $2.57
- Year Low
- $0.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.23
TCRX vs. The Competition
| Properties | TCRX | ACET | ACRV | FBIO |
|---|---|---|---|---|
| Market Cap | $47.21M | $77.22M | $73.62M | $91.35M |
| Shares Outstanding | $61.07M | $9.35M | $42.8M | $33.22M |
| P/E Ratio | -0.85 | -0.72 | -0.86 | 0.71 |
| EPS | -0.91 | -9.21 | -2.0 | 4.05 |
| Day Low | 0.7512 | 8.18 | 1.7 | 2.57 |
| Day High | 0.791 | 8.35 | 1.745 | 2.78 |
| Year Low | 0.716 | 6.01 | 1.25 | 1.9 |
| Year High | 2.57 | 17.44 | 3.56 | 4.53 |
| Average Price 50 | 0.91238 | 8.3166 | 1.6562 | 3.0442 |
| Average Price 200 | 1.07197 | 8.30956 | 1.8553 | 2.98445 |
| Volume | 523.99K | 39493 | 148.75K | 1M |
| Average Volume | - | - | - | - |